LexaGene to unveil rapid multipathogen genetic test this fall
Molecular diagnostics company LexaGene has announced that its MiQLab automated genetic analyzer for rapid pathogen detection will make its commercial launch before the end of September. Read More
Waters names new president, CEO
Waters has named Udit Batra, PhD, as its new president and chief executive officer (CEO), effective September 1. Read More
U.S. DOE launches National Virtual Biotechnology Laboratory

The U.S. Department of Energy (DOE) has launched the National Virtual Biotechnology Laboratory to unite the efforts of its 17 laboratories around the country in the fight against COVID-19.

Read More
Sirius, Cerulean ink European distribution deal
Laboratory automation equipment manufacturer Sirius Automation and tobacco test equipment provider Cerulean have signed an exclusive distribution deal. Read More
PerkinElmer predicts 12% growth in Q2
PerkinElmer has announced an updated outlook for the second quarter of 2020, predicting 12% revenue growth. Read More
Alkido Pharma advances anti-COVID-19 compound
Alkido Pharma has identified a compound with antiviral properties against COVID-19, under a master license agreement with the University of Maryland, Baltimore. Read More
LGC acquires antigens and antibodies company NAC
Life sciences company LGC has acquired the Native Antigen Company (NAC), an Oxford, U.K.-based supplier of infectious disease antigens and antibodies. Read More
Zymeworks, Merck to develop multispecific antibodies
Merck has signed a research and licensing agreement to develop multispecific antibody therapeutic candidates using platforms from clinical-stage biopharmaceutical company Zymeworks. Read More
AGC Biologics, Molecular Partners develop COVID-19 protein therapy
AGC Biologics has partnered with clinical-stage biotechnology company Molecular Partners to create a protein therapy against SARS-CoV-2, the virus that causes COVID-19. Read More
Takeda, Twist partner on biologics discovery
Twist Bioscience and Takeda Pharmaceutical have formed a partnership for access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter